Evidence map›Paper›PMID 23640496›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear.

Joseph E Aslan, Asako Itakura, Kristina M Haley, Garth W Tormoen, Cassandra P Loren, Sandra M Baker, Jiaqing Pang, Jonathan Chernoff, Owen J T McCarty

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. HAuClFrontiers in physiology · 2020
    Article
  9. Peri-procedural hemostasis disorders in surgical and transcatheter aortic valve implantation.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Lysine acetyltransfer supports platelet function.Journal of thrombosis and haemostasis : JTH · 2015
    Article
  17. Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins.Journal of the American Heart Association · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joseph E AslanDepartment of Biomedical Engineering, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR 97239, USA. aslanj@ohsu.edu
Asako Itakura
Kristina M Haley
Garth W Tormoen
Cassandra P Loren
Sandra M Baker
Jiaqing Pang
Jonathan Chernoff
Owen J T McCarty

Funding

Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
Targeting the Kinome in Neurofibromatosis type 1R01CA142928 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 2010 to 2019
$3.9M
NCI NIH HHS R01 CA142928NCI NIH HHS R01CA142928NHLBI NIH HHS R01 HL101972NHLBI NIH HHS R01HL101972
6 · The paper itself

Abstract

objectiveRho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. APPROACH AND

resultsStimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions.

conclusionsThese results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.

Indexed as

Platelet ActivationPlatelet AggregationSignal TransductionBlood PlateletsCarrier ProteinsCell ShapeEnzyme ActivationHumansLim KinasesMAP Kinase Kinase Kinasesp21-Activated KinasesPeptidesPhosphorylationPlatelet Membrane GlycoproteinsProtein Kinase InhibitorsPseudopodiaCarrier Proteinscollagen-related peptideLIMK1 protein, humanLim KinasesMAP Kinase Kinase Kinasesp21-Activated KinasesPeptidesPlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIProtein Kinase Inhibitorscell signalingplateletsignal transduction

Identifiers

PMID23640496
PMCPMC3938029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.